Search research articles
Contact Us
Filters
Showing results (731-740 of 753) with videos related to
Page
of 76
Sort By:
Nature Communications
|
August 8, 2025
Regional heterogeneity of the blood-brain barrier
Marie Blanchette, Kaja Bajc, Benjamin D Gastfriend, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
May 27, 2026
A Real-World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe Asthma
Dennis Thomas, Vanessa M McDonald, Gijo Thomas, et al.
The European Respiratory Journal
|
March 7, 2020
Mepolizumab effectiveness and identification of super-responders in severe asthma
Erin S Harvey, David Langton, Constance Katelaris, et al.
Respiratory Medicine
|
September 5, 2025
Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry
Erin S Harvey, Yuto Hamada, Sarah A Hiles, et al.
Plos Biology
|
August 22, 2023
Tightening the requirements for species diagnoses would help integrate DNA-based descriptions in taxonomic practice
Frank E Rheindt, Patrice Bouchard, Richard L Pyle, et al.
International Journal of Environmental Research and Public Health
|
June 24, 2022
'Breathing Fire': Impact of Prolonged Bushfire Smoke Exposure in People with Severe Asthma
Tesfalidet Beyene, Erin S Harvey, Joseph Van Buskirk, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 17, 2023
Impact of Landscape Fire Smoke Exposure on Patients With Asthma With or Without Laryngeal Hypersensitivity
Anne E Vertigan, Erin S Harvey, Tesfalidet Beyene, et al.
Chest
|
December 1, 2019
Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry
Eileen Wang, Michael E Wechsler, Trung N Tran, et al.
Allergy
|
August 26, 2023
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients
Dennis Thomas, Vanessa M McDonald, Sean Stevens, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 5, 2021
Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry
Dennis Thomas, Erin S Harvey, Vanessa M McDonald, et al.
Page
of 76
Search research articles
Search
Showing results (731-740 of 753) with videos related to
Sort By:
Page
of 76
Nature Communications
|
August 8, 2025
Regional heterogeneity of the blood-brain barrier
Marie Blanchette, Kaja Bajc, Benjamin D Gastfriend, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
May 27, 2026
A Real-World Controlled Multicentre Study Evaluating the Association Between Benralizumab Therapy and Major Outcomes in Severe Asthma
Dennis Thomas, Vanessa M McDonald, Gijo Thomas, et al.
The European Respiratory Journal
|
March 7, 2020
Mepolizumab effectiveness and identification of super-responders in severe asthma
Erin S Harvey, David Langton, Constance Katelaris, et al.
Respiratory Medicine
|
September 5, 2025
Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry
Erin S Harvey, Yuto Hamada, Sarah A Hiles, et al.
Plos Biology
|
August 22, 2023
Tightening the requirements for species diagnoses would help integrate DNA-based descriptions in taxonomic practice
Frank E Rheindt, Patrice Bouchard, Richard L Pyle, et al.
International Journal of Environmental Research and Public Health
|
June 24, 2022
'Breathing Fire': Impact of Prolonged Bushfire Smoke Exposure in People with Severe Asthma
Tesfalidet Beyene, Erin S Harvey, Joseph Van Buskirk, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 17, 2023
Impact of Landscape Fire Smoke Exposure on Patients With Asthma With or Without Laryngeal Hypersensitivity
Anne E Vertigan, Erin S Harvey, Tesfalidet Beyene, et al.
Chest
|
December 1, 2019
Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry
Eileen Wang, Michael E Wechsler, Trung N Tran, et al.
Allergy
|
August 26, 2023
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients
Dennis Thomas, Vanessa M McDonald, Sean Stevens, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 5, 2021
Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry
Dennis Thomas, Erin S Harvey, Vanessa M McDonald, et al.
Page
of 76